Insider Trading activities of Trius Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Trius Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Trius Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Trius Therapeutics Inc since 2005. The reporting company's ticker symbol is TRSX. The reporting company's CIK number is 1356857.
The total value of stock buying since 2005 is $50,281,491.
The total value of stock sales since 2005 is $1,444,811.
The total value of stock option exercises since 2005 is $355,266.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Trius Therapeutics Inc (TRSX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-07 0 $0 35,000 $340,325 20,000 $80,000
2013-06 0 $0 8,000 $67,489 0 $0
2013-05 0 $0 76,000 $594,183 20,000 $80,000
2013-04 0 $0 500 $3,550 0 $0
2013-03 0 $0 1,500 $10,650 0 $0
2012-06 0 $0 1,800 $10,800 0 $0
2012-03 0 $0 500 $2,520 106,310 $129,438
2012-02 0 $0 500 $2,815 0 $0
2012-01 0 $0 32,222 $177,647 4,000 $2,080
2011-12 0 $0 700 $5,250 0 $0
2011-11 0 $0 2,387 $17,992 0 $0
2011-10 0 $0 4,674 $33,429 4,000 $2,080
2011-09 0 $0 1,600 $10,430 0 $0
2011-08 2,133 $14,461 1,500 $9,410 4,070 $2,116
2011-07 0 $0 2,800 $21,195 0 $0
2011-06 0 $0 2,800 $22,543 0 $0
2011-05 0 $0 11,600 $86,089 0 $0
2011-04 0 $0 1,000 $5,508 0 $0
2011-03 0 $0 2,600 $17,486 0 $0
2011-02 0 $0 1,000 $5,500 0 $0
2010-12 0 $0 0 $0 22,700 $11,804
2010-11 1,000 $3,500 0 $0 7,364 $9,499
2010-10 0 $0 0 $0 29,651 $38,249
2010-08 10,052,706 $50,263,530 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Trius Therapeutics Inc insiders (TRSX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-07-22 Finn John (Chief Scientific Officer) Sale 1,000 12.10 12,100
2013-07-15 Finn John (Chief Scientific Officer) Sale 3,500 10.55 36,925
2013-07-12 Finn John (Chief Scientific Officer) Sale 5,000 10.10 50,500
2013-07-11 Morneau Michael (VP Finance & CAO) Sale 20,000 9.75 195,000
2013-07-11 Morneau Michael (VP Finance & CAO) Option Ex 20,000 4.00 80,000
2013-07-11 Finn John (Chief Scientific Officer) Sale 500 9.32 4,660
2013-07-10 Finn John (Chief Scientific Officer) Sale 1,000 8.58 8,580
2013-07-01 Prokocimer Philippe (Chief Medical Officer) Sale 2,000 8.14 16,280
2013-07-01 Bartizal Ken (Chief Development Officer) Sale 2,000 8.14 16,280
2013-06-12 Finn John (Chief Scientific Officer) Sale 3,000 9.08 27,249
2013-06-11 Finn John (Chief Scientific Officer) Sale 1,000 8.94 8,940
2013-06-04 Bartizal Ken (Chief Development Officer) Sale 2,000 7.90 15,800
2013-06-03 Prokocimer Philippe (Chief Medical Officer) Sale 2,000 7.75 15,500
2013-05-24 Prokocimer Philippe (Chief Medical Officer) Sale 12,000 7.93 95,124
2013-05-24 Bartizal Ken (Chief Development Officer) Sale 12,000 7.93 95,124
2013-05-14 Morneau Michael (VP Finance & CAO) Sale 20,000 7.75 155,000
2013-05-14 Morneau Michael (VP Finance & CAO) Option Ex 20,000 4.00 80,000
2013-05-14 Finn John (Chief Scientific Officer) Sale 5,000 8.10 40,510
2013-05-14 Bartizal Ken (Chief Development Officer) Sale 12,000 7.85 94,200
2013-05-13 Prokocimer Philippe (Chief Medical Officer) Sale 12,000 7.65 91,800
2013-05-10 Finn John (Chief Scientific Officer) Sale 3,000 7.48 22,425
2013-04-24 Finn John (Chief Scientific Officer) Sale 500 7.10 3,550
2013-03-15 Finn John (Chief Scientific Officer) Sale 1,500 7.10 10,650
2012-06-22 Schmid John P. (CFO and Secretary) Sale 1,800 6.00 10,800
2012-03-27 Schmid John P. (CFO and Secretary) Option Ex 5,000 1.29 6,450
2012-03-27 Stein Jeffrey (President and CEO) Option Ex 38,462 .52 20,000
2012-03-27 Eastham Karin (Director) Option Ex 6,000 3.50 21,000
2012-03-26 O'leary Brendan (Director) Option Ex 21,302 2.64 56,343
2012-03-26 Finn John (Chief Scientific Officer) Option Ex 20,000 .52 10,400
2012-03-26 Powell Michael (Director) Option Ex 9,302 1.29 11,999
2012-03-23 Prokocimer Philippe (Chief Medical Officer) Option Ex 6,244 .52 3,246
2012-03-01 Schmid John P. (CFO and Secretary) Sale 500 5.04 2,520
2012-02-02 Schmid John P. (CFO and Secretary) Sale 500 5.63 2,815
2012-01-19 Powell Michael (Director) Sale 2,600 5.64 14,661
2012-01-18 Powell Michael (Director) Sale 4,300 5.56 23,895
2012-01-17 Powell Michael (Director) Sale 16,100 5.43 87,423
2012-01-13 Prokocimer Philippe (Chief Medical Officer) Option Ex 4,000 .52 2,080
2012-01-13 Powell Michael (Director) Sale 8,522 5.46 46,572
2012-01-03 Schmid John P. (CFO and Secretary) Sale 700 7.28 5,096
2011-12-01 Schmid John P. (CFO and Secretary) Sale 700 7.50 5,250
2011-11-17 Bartizal Ken (Chief Development Officer) Sale 1,687 7.85 13,242
2011-11-07 Schmid John P. (CFO and Secretary) Sale 100 7.00 700
2011-11-01 Schmid John P. (CFO and Secretary) Sale 600 6.75 4,050
2011-10-31 Prokocimer Philippe (Chief Medical Officer) Sale 1,687 7.45 12,568
2011-10-27 Prokocimer Philippe (Chief Medical Officer) Sale 1,687 7.45 12,568
2011-10-26 Schmid John P. (CFO and Secretary) Sale 200 7.00 1,400
2011-10-11 Finn John (Chief Scientific Officer) Sale 500 6.19 3,095
2011-10-04 Prokocimer Philippe (Chief Medical Officer) Option Ex 4,000 .52 2,080
2011-10-03 Schmid John P. (CFO and Secretary) Sale 600 6.33 3,798
2011-09-15 Finn John (Chief Scientific Officer) Sale 1,000 6.47 6,470
2011-09-01 Schmid John P. (CFO and Secretary) Sale 600 6.60 3,960
2011-08-29 Truex Paul F (Director) Buy 2,000 6.80 13,600
2011-08-22 Thompson John Craig (Chief Commercial Officer) Buy 133 6.48 861
2011-08-22 Prokocimer Philippe (Chief Medical Officer) Option Ex 4,070 .52 2,116
2011-08-12 Finn John (Chief Scientific Officer) Sale 300 7.00 2,100
2011-08-11 Finn John (Chief Scientific Officer) Sale 200 7.00 1,400
2011-08-09 Finn John (Chief Scientific Officer) Sale 1,000 5.91 5,910
2011-07-20 Finn John (Chief Scientific Officer) Sale 500 8.00 4,000
2011-07-20 Schmid John P. (CFO and Secretary) Sale 100 8.00 800
2011-07-12 Finn John (Chief Scientific Officer) Sale 1,500 7.23 10,845
2011-07-01 Schmid John P. (CFO and Secretary) Sale 700 7.93 5,550
2011-06-09 Finn John (Chief Scientific Officer) Sale 2,000 8.09 16,187
2011-06-01 Schmid John P. (CFO and Secretary) Sale 800 7.94 6,356
2011-05-16 Finn John (Chief Scientific Officer) Sale 7,000 8.02 56,161
2011-05-16 Schmid John P. (CFO and Secretary) Sale 400 8.00 3,200
2011-05-12 Finn John (Chief Scientific Officer) Sale 1,500 7.00 10,500
2011-05-10 Finn John (Chief Scientific Officer) Sale 1,000 6.02 6,018
2011-05-05 Schmid John P. (CFO and Secretary) Sale 200 7.00 1,400
2011-05-03 Finn John (Chief Scientific Officer) Sale 800 6.00 4,800
2011-05-03 Schmid John P. (CFO and Secretary) Sale 200 6.00 1,200
2011-05-02 Schmid John P. (CFO and Secretary) Sale 500 5.62 2,810
2011-04-11 Finn John (Chief Scientific Officer) Sale 500 5.36 2,678
2011-04-01 Schmid John P. (CFO and Secretary) Sale 500 5.66 2,830
2011-03-30 Finn John (Chief Scientific Officer) Sale 200 6.00 1,200
2011-03-09 Finn John (Chief Scientific Officer) Sale 500 5.86 2,930
2011-03-01 Finn John (Chief Scientific Officer) Sale 500 7.00 3,500
2011-03-01 Schmid John P. (CFO and Secretary) Sale 1,400 7.04 9,856
2011-02-18 Finn John (Chief Scientific Officer) Sale 500 6.00 3,000
2011-02-17 Finn John (Chief Scientific Officer) Sale 500 5.00 2,500
2010-12-15 Stein Jeffrey (President and CEO) Option Ex 22,700 .52 11,804
2010-11-23 Truex Paul F (Director) Buy 1,000 3.50 3,500
2010-11-23 Truex Paul F (Director) Option Ex 7,364 1.29 9,499
2010-10-08 Kabakoff David S (Director) Option Ex 29,651 1.29 38,249
2010-08-06 Kpcb Pbd Associates, Llc (10% Owner) Buy 828,807 5.00 4,144,035
2010-08-06 Kpcb Pbd Founders Fund, Llc (10% Owner) Buy 4,901 5.00 24,505
2010-08-06 Versant Side Fund Iii, L.p. (10% Owner) Buy 914,529 5.00 4,572,645
2010-08-06 Kjellson Nina S (Director) Buy 1,227,333 5.00 6,136,665
2010-08-06 Pepper Douglas A (Other) Buy 1,227,333 5.00 6,136,665
2010-08-06 Sofinnova Venture Partners Vii L P (10% Owner) Buy 830,000 5.00 4,150,000
2010-08-06 Kpcb Pandemic & Bio Defense Fund Llc (10% Owner) Buy 823,906 5.00 4,119,530
2010-08-06 Cleveland Bruce A (Other) Buy 1,227,333 5.00 6,136,665
2010-08-06 Prism Venture Partners V-a Lp (10% Owner) Buy 1,194,035 5.00 5,970,175
2010-08-06 Atwood Brian G (Director) Buy 914,529 5.00 4,572,645
2010-08-06 Powell Michael (Director) Buy 830,000 5.00 4,150,000
2010-08-06 Kabakoff David S (Director) Buy 30,000 5.00 150,000

Insider trading activities including stock purchases, stock sales, and option exercises of TRSX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Trius Therapeutics Inc (symbol TRSX, CIK number 1356857) see the Securities and Exchange Commission (SEC) website.